Link to this page
Physician Data Query
Last uploaded:
August 27, 2019
Jump to:
| Preferred Name | atenolol | |
| Synonyms |
|
|
| Definitions |
A synthetic isopropylamino-propanol derivative used as an antihypertensive, hypotensive and antiarrhythmic. Atenolol acts as a peripheral, cardioselective beta blocker specific for beta-1 adrenergic receptors, without intrinsic sympathomimetic effects. It reduces exercise heart rates and delays atrioventricular conduction, with overall decreasing oxygen requirements. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C28836" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C28836" NCI Thesaurus) |
|
| ID |
http://purl.bioontology.org/ontology/PDQ/CDR0000590657 |
|
| CAS Registry |
29122-68-7
|
|
| cui |
C0004147
|
|
| DATE FIRST PUBLISHED |
2008-03-20
|
|
| Date last modified |
2010-11-01
|
|
| definition |
A synthetic isopropylamino-propanol derivative used as an antihypertensive, hypotensive and antiarrhythmic. Atenolol acts as a peripheral, cardioselective beta blocker specific for beta-1 adrenergic receptors, without intrinsic sympathomimetic effects. It reduces exercise heart rates and delays atrioventricular conduction, with overall decreasing oxygen requirements. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C28836" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C28836" NCI Thesaurus)
|
|
| NCI ID |
C28836
|
|
| notation |
CDR0000590657
|
|
| ORIG STY |
Drug/agent
|
|
| prefLabel |
atenolol
|
|
| tui |
T109 T121
|
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |
Create mapping